Life science news 11 May 2026: M&A momentum, artificial intelligence diagnostics and a record week for deal-making define an active seven days for the global life science industry. The week of 4 to 10 May 2026 produced a dense cluster of major acquisitions, a...
GSK has entered into an exclusive licensing agreement with Chinese biotech Suzhou Siran Biotechnology (SiranBio), securing global rights to the company's early-stage small interfering RNA (siRNA) therapy, SA030, in a deal worth up to $1.005 billion in potential...
For the life sciences sector, the global nursing shortage is not a background public health concern. It is a clinical trial staffing problem, a pharmaceutical market access problem, and a real-world evidence problem. The WHO's 2025 State of the World's Nursing report...
Life science news 4 May 2026: Eli Lilly's record $19.8 billion quarterly earnings, the FDA's real-time clinical trial revolution and a landmark week for UK regulatory reform define a momentous seven days for global life science. Eli Lilly reported worldwide revenue of...
Precision medicine is no longer a futuristic concept. Genomic panels, pharmacogenomic testing, advanced biomarker analysis, and individualized risk stratification tools are all available today. Yet for the vast majority of patients walking into a primary care office,...
India's largest pharmaceutical company, Sun Pharmaceutical Industries, has agreed to acquire New Jersey-based Organon & Co. in an all-cash transaction valued at $11.75 billion, marking the largest acquisition ever undertaken by an Indian biopharmaceutical company....
India's largest pharmaceutical company, Sun Pharmaceutical Industries, has agreed to acquire New Jersey-based Organon & Co. in an all-cash transaction valued at $11.75 billion, marking the largest acquisition ever undertaken by an Indian biopharmaceutical company....
Healthcare organisations invest significantly in psychosocial risk frameworks, governance structures and leadership development. Yet a new international study highlights a type of organisational risk that most of those frameworks are not designed to detect. It is a...
Life science news 27 April 2026: Eli Lilly's $7 billion in vivo CAR-T deal, Trump's psychedelics executive order and a first-ever gene therapy for hearing loss headline a landmark week across global life science. Eli Lilly announced on 20 April its acquisition of...
A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...
Boehringer Ingelheim AI Centre London: A New Frontier for Pharmaceutical Research German biopharmaceutical company Boehringer Ingelheim announced on 20 April 2026 the launch of a new centre for artificial intelligence and machine learning in King's Cross, London, as...
When ADHD and Menopause Overlap: Why Midlife Women Are Still Not Getting the Right Answers Girls and women have historically been overlooked in the ADHD diagnostic process and this is due, in part, to the fact that their symptoms often present differently than they do...
It’s no secret that the National Health Service (NHS) is suffering diagnostic pressure. The British Medical Association (BMA) reports that in November 2024, approximately 1.6 million people in England were waiting for a diagnostic test. That’s double the 0.8...
Blenrep Multiple Myeloma NHS England Rollout Makes UK a World First in Blood Cancer Treatment England has become the first country in the world to make GSK's belantamab mafodotin, marketed as Blenrep, available to multiple myeloma patients through a national health...
Life science news 20 April 2026: A landmark pancreatic cancer breakthrough, record-breaking biotech IPO, major UK investment announcements and a surge in FDA approvals define a momentous week for the global life science industry. Revolution Medicines reported on 13...
When US and Israeli military operations against Iran began on 28 February 2026, the consequences for global energy markets were immediate and predictable. What was less widely anticipated was the scale of the disruption now rippling through the life sciences sector....
UK Government's Life Sciences Large Investment Portfolio: A New Era for British Life Science The United Kingdom's life sciences sector received a significant policy boost on 14 April 2026 when the government formally announced the Life Sciences Large Investment...
The UK is currently navigating a silent epidemic that threatens not only our collective physical well-being but also our national productivity and the long-term sustainability of our healthcare infrastructure. Musculoskeletal (MSK) conditions now impact nearly one in...